Registered and potential indications of FDG PET/CT in breast carcinoma
The indication of 18F-fluorodeoxyglucose (FDG) imaging has been more disputed in breast carcinoma than in many other primary cancers (e.g. lung, head and neck, colorectal, lymphoma...) due to a limited sensitivity to detect the primary tumours in case of lobular or in situ forms or small sized tu...
Main Authors: | Balogova Sona, Vasovic Mina, Vereb Marika, Kaliska Lucia, Talbot Jean-Noël |
---|---|
Format: | Article |
Language: | English |
Published: |
Institute of Oncology, Sremska Kamenica, Serbia
2012-01-01
|
Series: | Archive of Oncology |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0354-7310/2012/0354-73101204152B.pdf |
Similar Items
-
Preoperative Lymph Node Staging by FDG PET/CT With Contrast Enhancement for Thyroid Cancer: A Multicenter Study and Comparison With Neck CT
by: Ari Chong, et al.
Published: (2017-03-01) -
18 F-FDG PET-CT for Staging of Conjunctival Melanoma
by: Andres Damian, et al.
Published: (2013-01-01) -
PET/CT in Multiple Myeloma: Beyond FDG
by: Federica Matteucci, et al.
Published: (2021-01-01) -
PET/CT in renal and bladder cancers
by: Balenović Antonija, et al.
Published: (2012-01-01) -
Prognostic value of 18F-FDG PET and PET/CT for assessment of treatment response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis
by: Sangwon Han, et al.
Published: (2020-10-01)